STOCKHOLM, Sweden, March 15, 2005 (PRIMEZONE) -- The affected competition authorities have now approved SCA's acquisition of Munksjo's tissue operations. The acquisition is expected to be completed in the beginning of the second quarter of 2005.
The acquired tissue operations will be integrated in SCA's business group, Tissue Europe.
From 2005, SCA's global tissue operations will be reported as a joint segment in the external accounts.
Stockholm, 15 March 2005
SVENSKA CELLULOSA AKTIEBOLAGET SCA (publ)
For further information, please contact: Jan Astrom, President and CEO. Phone +46 70-586 07 01. Peter Nyquist, Senior Vice President Communications and Investor Relations. Phone +46 70-575 29 06.
SCA produces and sells absorbent hygiene products, packaging solutions and publication papers. Based on customer needs, value-added products are produced for consumers, institutions, industry and the retail trade. Net sales amount to more than SEK 90 billion annually. At the beginning of 2005, the number of employees was approximately 50,000, in some 50 countries. The SCA share is traded on the stock exchanges in Stockholm and London, and can also be traded in the US in the form of ADRs (American Depositary Receipts, level 1).
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download: http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=80155&fn=wkr0001.pdf
-0-